Life Time Announces New Mountain Bike and Run Event - Coldwater Trail - in Northeast Alabama on Oct. 24 & 25
ANNISTON, Ala., March 28, 2025 /PRNewswire/ -- Life Time (NYSE: LTH), the nation's premier healthy lifestyle brand, announces the launch of the Life Time Coldwater Trail MTB & Run presented by Sunny King Auto. This new mountain bike and trail run event is set for October 24 and 25, 2025 in Anniston, Alabama and adds to the Company's portfolio of nearly 30 iconic athletic events across the country.
Life Time, owner and producer of this new endurance event, invites mountain bikers and trail runners to discover the hidden gem of Coldwater Mountain in Anniston, Alabama. The event will offer 50K and 100K distances for cyclists, as well as 15K and 50K distances for runners, and will showcase portions of the more than 4,000 acres of land that make up the picturesque Coldwater Mountain Trail System.
'Over the past few years, we've been searching the southeast to find the right venue to bring a new Leadville qualifier and have found that in Anniston,' said Kimo Seymour, President of Media and Events at Life Time. 'Life Time is dedicated to creating unforgettable experiences and meaningful partnerships with local host communities. We're excited for Anniston to be our latest partner in that as we welcome trail runners and mountain bikers from around the globe.'
As a rising destination for outdoor recreation and in what the Alabama Tourism Department has declared 'The Year of Alabama Trails,' Anniston and the surrounding Calhoun County have gone all in on their investment in outdoor recreation.
The vision and dedication from the community that transformed Coldwater Mountain into a premier riding and running destination is what caught the attention of Life Time.
'Thanks to the hard work of NEABA members and the support of the local community, Coldwater Mountain Bike Trail System is quickly becoming the go-to place for mountain biking in the southeast,' said Ken Hickman, President of the Northeast Alabama Bicycle Association. 'The trails offer a unique blend of natural beauty and technical challenges, making them a favorite among riders and offering something for everyone. We're excited to be working with Life Time to highlight what Coldwater has to offer.'
The Life Time Coldwater Trail MTB & Run will offer a variety of race categories to accommodate both competitive and recreational participants, ranging from technical mountain bike races to scenic trail runs through Anniston's lush forests and rugged terrain. The course will showcase some of the area's most iconic trails, many of which have been crafted and maintained through partnerships between local volunteers, trail advocacy groups, and the City of Anniston. To date, more than $4 million has been invested in the development of the Coldwater Mountain Trail area from a variety of sources including the City of Anniston, state grants and Innovate Alabama.
'Over the past two years Innovate Alabama has invested nearly $20 million in outdoor recreation infrastructure across the state to further Alabama's position as a home for an outdoor lifestyle, with Coldwater Mountain being one of those key early projects,' stated T.C. McLemore, Executive Director of Outdoor Recreation Programs at Innovate Alabama. 'Life Time's recognition of not just Coldwater as a unique natural asset but of east Alabama's community of mountain bikers and outdoor enthusiasts validates that investment.'
The event also will feature a weekend of family-friendly activities, live music, and local food vendors, providing an opportunity for attendees to experience Anniston's southern hospitality.
The Life Time Coldwater Trail MTB & Run expands Life Time's portfolio of owned and produced athletic events, and will serve as a qualifying event for Life Time's Leadville Trail 100 MTB presented by Kenetik and Leadville Trail 100 Run presented by La Sportiva. It is the most easterly Leadville qualifying event in the country. For more information on the Leadville Race Series and how to qualify, visit www.leadvilleraceseries.com/lottery-qualification.
Registration for the Life Time Coldwater Trail MTB & Run is now open. For more information on the event, including race options and the full weekend schedule, visit coldwatertrailrace.com or follow along on Instagram.
About Life Time
Life Time (NYSE: LTH) empowers people to live healthy, happy lives through its portfolio of more than 175 athletic country clubs across the United States and Canada, complimentary, comprehensive healthy way of life app and nearly 30 of the most iconic athletic events in the country. The health and wellness pioneer uniquely serves people 90 days to 90+ years old through its healthy living, healthy aging, healthy entertainment communities and ecosystem, along with a range of healthy way of life programs and information, and trusted LTH nutritional supplements and products. Life Time was recently certified as a Great Place to Work®, reinforcing its commitment to fostering an exceptional workplace culture on behalf of more than 42,000 dedicated team members.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 minutes ago
- Yahoo
Here's Why We Think Gorman-Rupp (NYSE:GRC) Might Deserve Your Attention Today
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks' without any revenue, let alone profit. But the reality is that when a company loses money each year, for long enough, its investors will usually take their share of those losses. Loss-making companies are always racing against time to reach financial sustainability, so investors in these companies may be taking on more risk than they should. So if this idea of high risk and high reward doesn't suit, you might be more interested in profitable, growing companies, like Gorman-Rupp (NYSE:GRC). Now this is not to say that the company presents the best investment opportunity around, but profitability is a key component to success in business. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. If a company can keep growing earnings per share (EPS) long enough, its share price should eventually follow. That makes EPS growth an attractive quality for any company. Over the last three years, Gorman-Rupp has grown EPS by 14% per year. That's a pretty good rate, if the company can sustain it. One way to double-check a company's growth is to look at how its revenue, and earnings before interest and tax (EBIT) margins are changing. Gorman-Rupp reported flat revenue and EBIT margins over the last year. While this doesn't ring alarm bells, it may not meet the expectations of growth-minded investors. You can take a look at the company's revenue and earnings growth trend, in the chart below. Click on the chart to see the exact numbers. View our latest analysis for Gorman-Rupp Fortunately, we've got access to analyst forecasts of Gorman-Rupp's future profits. You can do your own forecasts without looking, or you can take a peek at what the professionals are predicting. It's pleasing to see company leaders with putting their money on the line, so to speak, because it increases alignment of incentives between the people running the business, and its true owners. So it is good to see that Gorman-Rupp insiders have a significant amount of capital invested in the stock. Notably, they have an enviable stake in the company, worth US$215m. Coming in at 21% of the business, that holding gives insiders a lot of influence, and plenty of reason to generate value for shareholders. Very encouraging. It means a lot to see insiders invested in the business, but shareholders may be wondering if remuneration policies are in their best interest. Our quick analysis into CEO remuneration would seem to indicate they are. The median total compensation for CEOs of companies similar in size to Gorman-Rupp, with market caps between US$400m and US$1.6b, is around US$3.7m. The Gorman-Rupp CEO received US$2.0m in compensation for the year ending December 2024. That seems pretty reasonable, especially given it's below the median for similar sized companies. CEO remuneration levels are not the most important metric for investors, but when the pay is modest, that does support enhanced alignment between the CEO and the ordinary shareholders. Generally, arguments can be made that reasonable pay levels attest to good decision-making. One important encouraging feature of Gorman-Rupp is that it is growing profits. The fact that EPS is growing is a genuine positive for Gorman-Rupp, but the pleasant picture gets better than that. Boasting both modest CEO pay and considerable insider ownership, you'd argue this one is worthy of the watchlist, at least. Even so, be aware that Gorman-Rupp is showing 1 warning sign in our investment analysis , you should know about... While opting for stocks without growing earnings and absent insider buying can yield results, for investors valuing these key metrics, here is a carefully selected list of companies in the US with promising growth potential and insider confidence. Please note the insider transactions discussed in this article refer to reportable transactions in the relevant jurisdiction. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
an hour ago
- Yahoo
A Look At The Fair Value Of Keysight Technologies, Inc. (NYSE:KEYS)
Using the 2 Stage Free Cash Flow to Equity, Keysight Technologies fair value estimate is US$180 Current share price of US$167 suggests Keysight Technologies is potentially trading close to its fair value Analyst price target for KEYS is US$183, which is 2.1% above our fair value estimate Today we will run through one way of estimating the intrinsic value of Keysight Technologies, Inc. (NYSE:KEYS) by taking the forecast future cash flows of the company and discounting them back to today's value. Our analysis will employ the Discounted Cash Flow (DCF) model. Before you think you won't be able to understand it, just read on! It's actually much less complex than you'd imagine. We would caution that there are many ways of valuing a company and, like the DCF, each technique has advantages and disadvantages in certain scenarios. If you still have some burning questions about this type of valuation, take a look at the Simply Wall St analysis model. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. We use what is known as a 2-stage model, which simply means we have two different periods of growth rates for the company's cash flows. Generally the first stage is higher growth, and the second stage is a lower growth phase. To start off with, we need to estimate the next ten years of cash flows. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years. A DCF is all about the idea that a dollar in the future is less valuable than a dollar today, so we discount the value of these future cash flows to their estimated value in today's dollars: 2026 2027 2028 2029 2030 2031 2032 2033 2034 2035 Levered FCF ($, Millions) US$1.18b US$1.36b US$1.47b US$1.58b US$1.67b US$1.75b US$1.82b US$1.89b US$1.96b US$2.02b Growth Rate Estimate Source Analyst x4 Analyst x3 Analyst x1 Analyst x1 Est @ 5.58% Est @ 4.79% Est @ 4.23% Est @ 3.85% Est @ 3.57% Est @ 3.38% Present Value ($, Millions) Discounted @ 7.8% US$1.1k US$1.2k US$1.2k US$1.2k US$1.1k US$1.1k US$1.1k US$1.0k US$993 US$952 ("Est" = FCF growth rate estimated by Simply Wall St)Present Value of 10-year Cash Flow (PVCF) = US$11b We now need to calculate the Terminal Value, which accounts for all the future cash flows after this ten year period. The Gordon Growth formula is used to calculate Terminal Value at a future annual growth rate equal to the 5-year average of the 10-year government bond yield of 2.9%. We discount the terminal cash flows to today's value at a cost of equity of 7.8%. Terminal Value (TV)= FCF2035 × (1 + g) ÷ (r – g) = US$2.0b× (1 + 2.9%) ÷ (7.8%– 2.9%) = US$43b Present Value of Terminal Value (PVTV)= TV / (1 + r)10= US$43b÷ ( 1 + 7.8%)10= US$20b The total value is the sum of cash flows for the next ten years plus the discounted terminal value, which results in the Total Equity Value, which in this case is US$31b. To get the intrinsic value per share, we divide this by the total number of shares outstanding. Compared to the current share price of US$167, the company appears about fair value at a 7.0% discount to where the stock price trades currently. Valuations are imprecise instruments though, rather like a telescope - move a few degrees and end up in a different galaxy. Do keep this in mind. The calculation above is very dependent on two assumptions. The first is the discount rate and the other is the cash flows. You don't have to agree with these inputs, I recommend redoing the calculations yourself and playing with them. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Keysight Technologies as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 7.8%, which is based on a levered beta of 1.130. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business. Check out our latest analysis for Keysight Technologies Strength Debt is not viewed as a risk. Weakness Earnings declined over the past year. Opportunity Annual earnings are forecast to grow for the next 3 years. Current share price is below our estimate of fair value. Threat Annual earnings are forecast to grow slower than the American market. Although the valuation of a company is important, it is only one of many factors that you need to assess for a company. DCF models are not the be-all and end-all of investment valuation. Preferably you'd apply different cases and assumptions and see how they would impact the company's valuation. For instance, if the terminal value growth rate is adjusted slightly, it can dramatically alter the overall result. For Keysight Technologies, we've compiled three relevant items you should consider: Risks: Consider for instance, the ever-present spectre of investment risk. We've identified 1 warning sign with Keysight Technologies , and understanding it should be part of your investment process. Future Earnings: How does KEYS's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart. Other High Quality Alternatives: Do you like a good all-rounder? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing! PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the NYSE every day. If you want to find the calculation for other stocks just search here. — Investing narratives with Fair Values Suncorp's Next Chapter: Insurance-Only and Ready to Grow By Robbo – Community Contributor Fair Value Estimated: A$22.83 · 0.1% Overvalued Thyssenkrupp Nucera Will Achieve Double-Digit Profits by 2030 Boosted by Hydrogen Growth By Chris1 – Community Contributor Fair Value Estimated: €14.40 · 0.3% Overvalued Tesla's Nvidia Moment – The AI & Robotics Inflection Point By BlackGoat – Community Contributor Fair Value Estimated: $359.72 · 0.1% Overvalued View more featured narratives — Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Shareholders in Methode Electronics (NYSE:MEI) are in the red if they invested three years ago
Methode Electronics, Inc. (NYSE:MEI) shareholders will doubtless be very grateful to see the share price up 77% in the last quarter. But that doesn't change the fact that the returns over the last three years have been disappointing. In that time, the share price dropped 72%. Some might say the recent bounce is to be expected after such a bad drop. The rise has some hopeful, but turnarounds are often precarious. It's worthwhile assessing if the company's economics have been moving in lockstep with these underwhelming shareholder returns, or if there is some disparity between the two. So let's do just that. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. Methode Electronics isn't currently profitable, so most analysts would look to revenue growth to get an idea of how fast the underlying business is growing. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. As you can imagine, fast revenue growth, when maintained, often leads to fast profit growth. In the last three years Methode Electronics saw its revenue shrink by 3.1% per year. That is not a good result. Having said that the 20% annualized share price decline highlights the risk of investing in unprofitable companies. We're generally averse to companies with declining revenues, but we're not alone in that. Don't let a share price decline ruin your calm. You make better decisions when you're calm. The image below shows how earnings and revenue have tracked over time (if you click on the image you can see greater detail). We like that insiders have been buying shares in the last twelve months. Even so, future earnings will be far more important to whether current shareholders make money. If you are thinking of buying or selling Methode Electronics stock, you should check out this free report showing analyst profit forecasts. As well as measuring the share price return, investors should also consider the total shareholder return (TSR). Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. It's fair to say that the TSR gives a more complete picture for stocks that pay a dividend. In the case of Methode Electronics, it has a TSR of -69% for the last 3 years. That exceeds its share price return that we previously mentioned. This is largely a result of its dividend payments! Methode Electronics provided a TSR of 11% over the last twelve months. But that return falls short of the market. But at least that's still a gain! Over five years the TSR has been a reduction of 10% per year, over five years. So this might be a sign the business has turned its fortunes around. It's always interesting to track share price performance over the longer term. But to understand Methode Electronics better, we need to consider many other factors. For instance, we've identified 1 warning sign for Methode Electronics that you should be aware of. Methode Electronics is not the only stock that insiders are buying. For those who like to find lesser know companies this free list of growing companies with recent insider purchasing, could be just the ticket. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
